Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA–Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy

Overview of attention for article published in this source, April 2018

Altmetric Badge

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 59 Dimensions

Readers on

mendeley: 98 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 11 X posts from 9 X users, with an upper bound of 9,159 followers.

RT @HGTJournal: Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocy…

28 May 2018

Reply Repost Favourite

Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocytes for Ovarian Cancer Therapy (Free access through May 30): https://t.co/yKswTCoUfI

27 May 2018

Reply Repost Favourite

RT @HGTJournal: Development of Anti-Human Mesothelin-Targeted Chimeric Antigen Receptor Messenger RNA-Transfected Peripheral Blood Lymphocy…

24 May 2018

Reply Repost Favourite

23 May 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.